Unknown PHASE2 INTERVENTIONAL NCT00024193

Chemotherapy and Surgery Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Neuroblastoma

A Study Of The Treatment Of Metastatic Neuroblastoma In Children More Than One Year Of Age At Diagnosis

Sponsor: Children's Cancer and Leukaemia Group

Interventions busulfan cisplatin conventional surgery cyclophosphamide doxorubicin hydrochloride etoposide filgrastim melphalan peripheral blood stem cell transplantation vincristine sulfate

Updated 5 times since 2017 Last updated: Aug 6, 2013 Started: Apr 30, 1999

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Neuroblastoma, this trial is ongoing. The trial is conducted by Children's Cancer and Leukaemia Group and has accumulated 5 data snapshots since 1999. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

First recorded

Apr 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Children's Cancer and Leukaemia Group
Societe Francaise Oncologie Pediatrique

Data source: National Cancer Institute (NCI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Villejuif, France